Glibenclamide 5mg + Metformin Hydrochloride 500mg Tablets

Glibenclamide 5mg + Metformin Hydrochloride 500mg combines a sulfonylurea with metformin for type 2 diabetes when both increased insulin release and improved glucose handling are needed. It is an oral maintenance treatment alongside diet and physical activity.
Swallow the tablet with a meal and water. Keep meal times consistent and avoid skipping food after a dose, because glibenclamide can cause prolonged hypoglycaemia.
Glibenclamide stimulates insulin release from pancreatic beta cells. Metformin reduces liver glucose production and improves the response of tissues to insulin.
Low glucose, nausea, diarrhoea, stomach discomfort and weight gain may occur. Confusion, collapse, persistent vomiting or unusual breathlessness needs urgent assessment.
Kidney or liver impairment can increase adverse effects, including prolonged hypoglycaemia. Dehydration, major surgery or contrast imaging can require temporary metformin interruption. Long-term use can lower vitamin B12.
The complementary actions can improve glucose control when a single oral medicine is insufficient.
Sweating, shaking, hunger, palpitations or sudden weakness can occur. If awake and able to swallow, take a fast-acting glucose source and recheck glucose after about 15 minutes.
Yes. Glibenclamide can have a prolonged effect, especially with kidney problems. Severe or recurrent hypoglycaemia needs urgent medical assessment.
Alcohol can increase hypoglycaemia risk and, particularly with heavy intake or dehydration, add to metformin-related lactic-acidosis risk.
No. The insulin-releasing component needs functioning pancreatic beta cells, and the combination does not replace insulin or treat ketoacidosis.
Metformin can reduce B12 absorption. Anaemia, persistent tiredness or new tingling may need testing rather than being assumed to be diabetes alone.
Sulfonylurea: a class of medicines stimulating insulin release. Beta cell: a pancreatic cell that makes insulin. Hypoglycaemia: low blood glucose. Lactic acidosis: a serious build-up of lactic acid, associated with metformin accumulation in certain illnesses.; AR: Glibenclamide 5mg + Metformin Hydrochloride 500mg أقراص; FR: Glibenclamide 5mg + Metformin Hydrochloride 500mg comprimés; PT: Glibenclamide 5mg + Metformin Hydrochloride 500mg comprimidos; ES: Glibenclamide 5mg + Metformin Hydrochloride 500mg comprimidos; RU: Glibenclamide 5mg + Metformin Hydrochloride 500mg таблетки; ID: Glibenclamide 5mg + Metformin Hydrochloride 500mg tablet; VI: Glibenclamide 5mg + Metformin Hydrochloride 500mg viên nén; MS: Glibenclamide 5mg + Metformin Hydrochloride 500mg tablet; TL: Glibenclamide 5mg + Metformin Hydrochloride 500mg mga tableta; ZH-SG: Glibenclamide 5mg + Metformin Hydrochloride 500mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Glibenclamide 5mg + Metformin Hydrochloride 500mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Glibenclamide 5mg + Metformin Hydrochloride 500mg Tablets